Literature DB >> 18380984

Thrombophilia screening: little role for the JAK2V617F mutation.

Pier Mannuccio Mannucci, Flora Peyvandi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18380984     DOI： 10.4065/83.4.398

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  2 in total

1.  Budd-Chiari Syndrome in a Patient with JAK-2 V617F and Factor V G1691A Mutations.

Authors:  J S Velarde-Félix; J Sanchez-Zazueta; F P Gonzalez-Ibarra; J A González-Valdez; B Salcido-Gómez; E Gallardo-Angulo; J Murillo-Llanes
Journal:  West Indian Med J       Date:  2014-06-10       Impact factor: 0.171

Review 2.  The first report of a JAK2 V617F-positive myeloproliferative neoplasm with initial manifestation as a rare pampiniform venous plexus thrombosis and review of the literature.

Authors:  Jeremy Jacobs; Deva Sharma; Cindy Vnencak-Jones
Journal:  J Thromb Thrombolysis       Date:  2021-07-09       Impact factor: 2.300
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.